相似文献
1
UCH-L1 in DLBCL: marker or target?
Blood. 2016 Mar 24;127(12):1524-5. doi: 10.1182/blood-2016-01-689984.
2
UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma.
Blood. 2016 Mar 24;127(12):1564-74. doi: 10.1182/blood-2015-07-656678. Epub 2015 Dec 23.
3
Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas.
Blood. 2005 Apr 1;105(7):2924-32. doi: 10.1182/blood-2004-10-3820. Epub 2004 Dec 9.
4
Cell-of-origin of diffuse large B-cell lymphomas determined by the Lymph2Cx assay: better prognostic indicator than Hans algorithm.
Oncotarget. 2017 Mar 28;8(13):22014-22022. doi: 10.18632/oncotarget.15782.
5
Clinicopathological study of gene rearrangement and microRNA expression of primary central nervous system diffuse large B-cell lymphomas.
Int J Clin Exp Pathol. 2013 Sep 15;6(10):2048-55. eCollection 2013.
6
FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas.
Leukemia. 2016 Mar;30(3):605-16. doi: 10.1038/leu.2015.299. Epub 2015 Oct 26.
7
An oxidative stress-based mechanism of doxorubicin cytotoxicity suggests new therapeutic strategies in ABC-DLBCL.
Blood. 2016 Dec 15;128(24):2797-2807. doi: 10.1182/blood-2016-03-705814. Epub 2016 Oct 13.
8
MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type.
Histopathology. 2008 Aug;53(2):205-17. doi: 10.1111/j.1365-2559.2008.03076.x.
9
Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell.
Leukemia. 2008 Feb;22(2):400-5. doi: 10.1038/sj.leu.2405019. Epub 2007 Nov 8.
10
BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma.
Am J Pathol. 2004 Jul;165(1):159-66. doi: 10.1016/s0002-9440(10)63284-1.
本文引用的文献
1
UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma.
Blood. 2016 Mar 24;127(12):1564-74. doi: 10.1182/blood-2015-07-656678. Epub 2015 Dec 23.
2
UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1α.
Nat Commun. 2015 Jan 23;6:6153. doi: 10.1038/ncomms7153.
3
Ubiquitin carboxyl hydrolase L1 significance for human diseases.
Protein Pept Lett. 2014 Jul;21(7):624-30. doi: 10.2174/0929866521666140403125959.
4
The regulation of the UCH-L1 gene by transcription factor NF-κB in podocytes.
Cell Signal. 2013 Jul;25(7):1574-85. doi: 10.1016/j.cellsig.2013.03.018. Epub 2013 Apr 6.
5
Ubiquitin C-terminal hydrolase l1 in tumorigenesis.
Biochem Res Int. 2012;2012:123706. doi: 10.1155/2012/123706. Epub 2012 Jul 1.
6
PU.1-dependent regulation of UCH L1 expression in B-lymphoma cells.
Leuk Lymphoma. 2011 Jul;52(7):1336-47. doi: 10.3109/10428194.2011.562571. Epub 2011 Apr 20.
7
The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signaling.
Leukemia. 2010 Sep;24(9):1641-55. doi: 10.1038/leu.2010.138. Epub 2010 Jun 24.
8
Expression and functional studies of ubiquitin C-terminal hydrolase L1 regulated genes.
PLoS One. 2009 Aug 26;4(8):e6764. doi: 10.1371/journal.pone.0006764.
9
Positive reciprocal regulation of ubiquitin C-terminal hydrolase L1 and beta-catenin/TCF signaling.
PLoS One. 2009 Jun 18;4(6):e5955. doi: 10.1371/journal.pone.0005955.
10
Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells.
Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2253-8. doi: 10.1073/pnas.0308411100.
Zotero 插件